arrow
Back
S

Sanjay Popat

Royal Marsden Hospital

65H-index
799Paper Count
3.0WCitation Count
Published Papers 231
Publication Date
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial
err2026-08-24
err0
PREAI
errXiuning Le; Antonio Passaro; Yuanyuan Zhao; Yan Huang; Janessa Laskin; Delvys Rodriguez-Abreu; Antonio Calles; Lyudmila Bazhenova; Giuseppe Lo Russo; Natasha B Leighl; Federico Cappuzzo; Nicolas Girard; Sanjay Popat; Wenfeng Fang; Yongzhong Luo; Wenting Li; Zhiyong He; Hui Zhao; Mingjun Li; Qibin Song
errShare
errSave
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation
err2026-08-06
err0
PREAI
errH.A. Wakelee; M-J. Ahn; J. Bradley; S. Popat; K. Kelly; A-M. Baird; O. Ozyilkan; J. Yu; S.Y. Lee; N. Yanagitani; M. Johnson; A. Sánchez-Hernández; A. Szczesna; K. Cuppens; E. Yao; C. Parsons; C. Matheny; Z. Zhang; M.N. White; J.J. Hsu
errShare
errSave
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives
err2026-08-03
err0
PREAI
errRoss A. Soo; Ji-Youn Han; James Chung-Man Ho; Calvin S.H. Ng; Lynette L.S. Teo; Elaine Shum; Sanjay Popat
errShare
errSave
Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study
err2026-06-17
err0
PREAI
errKevin B W Groot Lipman; Rianne Wittenberg; Mateus de Oliveira Taveira; Illaa Smesseim; Alexander M Th Schmitz; Thierry N Boellaard; Kalina Chupetlovska; Mohamed A Abdelatty; Liliana Petrychenko; Neeraj Jain; Francesco M Arico; Valerio Pugliese; Robin Cornelissen; Ties A Mulders; Fenneke Zwierenga; Birgitta I Hiddinga; Mena Shenouda; Samuel G Armato; Sanjay Popat; Solange Peters
errShare
errSave
PP01.55: RASolve 301: A Phase 3 Study of Daraxonrasib (RMC-6236) vs. Docetaxel in Patients with Previously Treated RAS-Mutant NSCLC
err2026-05-07
err0
PREAI
errFerdinandos Skoulidis; Kathryn C. Arbour; Sanjay Popat; Colin R. Lindsay; Hidehito Hironouchi; Gérard Zalcman; Alessandra Curioni-Fontecedro; Jarushka Naidoo; Adrianus J. de Langen; Jing He; Erica Su; Minoti Hiremath; Lawrence Watt; Achim Rittmeyer; Melissa Johnson
errShare
errSave
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
err2026-04-28
err0
errOAAI
errHidetoshi Hayashi; Byoung Chul Cho; David R. Spigel; Nicolas Girard; Se-Hoon Lee; Shun Lu; Sanjay Popat; James Chih-Hsin Yang; Antonio Passaro; Clarissa Baldotto; Maya Gottfried; Josiane Mourão Dias; Ana Caroline Zimmer Gelatti; Bo Wang; Julian Kam; Seema Sethi; Sujay Shah; Medha Kamat; Jiarui Zhang; Joshua C. Curtin
errShare
errSave
Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 Analysis
err2026-04-16
err0
errOAAI
errAlexander Drilon; Byoung Chul Cho; D Ross Camidge; Misako Nagasaka; Benjamin Besse; Benjamin Solomon; Koichi Goto; Jürgen Wolf; Sanjay Popat; Enriqueta Felip; Nong Yang; Adrianus Johannes de Langen; Shun Lu; Vamsidhar Velcheti; Andrew L Lin; Christophe Y Calvet; Li Li; Marina Tschaika; Salman Afsar; Haisu Yang; Jessica J Lin
errShare
errSave
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
err2026-04-04
err0
errOAAI
errRyan A. McMahon; Kevin Lee Min Chua; Corinne Faivre-Finn; Andrea R. Filippi; Lizza E.L. Hendriks; Thomas John; Stephen V. Liu; Fiona McDonald; Sanjay Popat; Stephanie P.L. Saw; Pablo Munoz-Schuffenegger; Vamsidhar Velcheti; Alexander V. Louie; Shankar Siva
errShare
errSave
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
err2026-02-04
err0
errOAAI
errBenjamin Besse; Jessica J. Lin; Lyudmila Bazhenova; Koichi Goto; Adrianus Johannes de Langen; Dong-Wan Kim; Jürgen Wolf; Christoph Springfeld; Sanjay Popat; Darren W. T. Lim; Misako Nagasaka; Jung Yong Hong; Christina S. Baik; Alice Hervieu; Victor Moreno; Nong Yang; Kanthi Kollengode; Haisu Yang; Yuanfang Xu; Christophe Y. Calvet; Yong Yuan; Amy B. Hammell; Alexander Drilon; Benjamin J. Solomon
errShare
errSave
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
errNature
IF48.5
err2026-01-14
err0
errOAAI
errKevin W. Ng; Jesse Boumelha; Katey S. S. Enfield; Jorge Almagro; Hongui Cha; Oriol Pich; Takahiro Karasaki; David A. Moore; Roberto Salgado; Monica Sivakumar; George Young; Miriam Molina-Arcas; Sophie de Carné Trécesson; Panayiotis Anastasiou; Annika Fendler; Lewis Au; Scott T. C. Shepherd; Carlos Martínez-Ruiz; Clare Puttick; James R. M. Black; Thomas B. K. Watkins; Hyemin Kim; Seohee Shim; Nikhil Faulkner; Jan Attig; Selvaraju Veeriah; Neil Magno; Sophia Ward; Alexander M. Frankell; Maise Al Bakir; Emilia L. Lim; Mark S. Hill; Gareth A. Wilson; Daniel E. Cook; Nicolai J. Birkbak; Axel Behrens; Nadia Yousaf; Sanjay Popat; Allan Hackshaw; Crispin T. Hiley; Kevin Litchfield; Nicholas McGranahan; Mariam Jamal-Hanjani; James Larkin; Se-Hoon Lee; Samra Turajlic; Charles Swanton; Julian Downward; George Kassiotis
errShare
errSave
Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG)
err2026-01-09
err0
errOAAI
errOmar Abdel-Rahman; Paul Taylor; Mary O’Brien; Jo Raskin; Claudio Dazzi; Veerle Surmont; Sabrina Zonato; Robin Young; Anne-Claire Toffart; Petra Jankowska; Adam Hassani; Sandrine Marreaud; Luc Boone; Sanjay Popat
errShare
errSave
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
err2025-11-03
err0
errOAAI
errRachel E. Sanborn; Caicun Zhou; Ke-Jing Tang; Byoung Chul Cho; Susanna Cheng; Sanjay Popat; Akira Ono; Shun Lu; Margarita Majem; Andres Aguilar; Maria Del Rosario Garcia Campelo; Hidetoshi Hayashi; Kang-yun Lee; Se-Hoon Lee; Angelo Delmonte; Jorge Alatorre-Alexander; Gary Richardson; Victor Santos; Christophe Dooms; Joshua K. Sabari; Catherine A. Shu; Nicolas Girard; Aaron S. Mansfield; Keunchil Park; Yichuan Xia; Archan Bhattacharya; Nasuh Buyukkaramikli; Nolen Perualila; Joris Diels; Sandip Acharya; Conor Chandler; Irina Proskorovsky; Lindsay Dearden; Honeylet Wortman-Vayn; Parthiv J. Mahadevia; Roland E. Knoblauch; Trishala Agrawal; Mahadi Baig; Enriqueta Felip
errShare
errSave
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
err2025-10-14
err0
PREAI
errMariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans
errShare
errSave
International guidelines on the diagnosis and treatment of NUT carcinoma
err2025-07-31
err0
errOAAI
errYu Zhang; Qi Zhang; Yue Hao; Jia Luo; Yingshi Piao; Wenxian Wang; Zhengbo Song; Ziming Li; Luka Brcic; Aijun Liu; Jinpu Yu; Yasuhiro Tsutani; Wenzhao Zhong; Wenfeng Fang; Zhijie Wang; Shengxiang Ren; Athanasios G. Papavassiliou; Yongchang Zhang; Jingjing Liu; Shirong Zhang; Xiuyu Cai; Ayten Kayi Cangir; Anwen Liu; Wen Li; Filippo Lococo; Ping Zhan; Hongbing Liu; Tangfeng Lv; Liyun Miao; Lingfeng Min; Helmut Popper; Yu Chen; Jingping Yuan; Feng Wang; Zhansheng Jiang; Gen Lin; Long Huang; Xingxiang Pu; Rongbo Lin; Kalevi Kairemo; Weifeng Liu; Chuangzhou Rao; Dongqing Lv; Zongyang Yu; Ashrafian Leanne; Xiaoyan Li; Chuanhao Tang; Hifzur R. Siddique; Chengzhi Zhou; Junping Zhang; Junli Xue; Vishal Shelat; Hui Guo; Qian Chu; Rui Meng; Fatemeh Ardeshir; Jingxun Wu; Rui Zhang; Jin Zhou; Robert A. Kratzke; Zhengfei Zhu; Yongheng Li; Hong Qiu; Fan Xia; Fiorella Calabrese; Yang Xia; Alessandro Wasum Mariani; Yuanyuan Lu; Xiaofeng Chen; Mark A. Klein; Rui Ge; Enyong Dai; Axel H. Schönthal; Yu Han; Zhenying Guo; Jian Zhang; Yinghua Ji; Xianbin Liang; Hongmei Zhang; Xuelei Ma; Marco Chiappetta; Xuewen Liu; Francoise Galateau Salle; Yu Yao; Malgorzata Szolkowska; Weiwei Pan; Fei Pang; Fan Wu; Stefan B. Watzka; Liping Wang; Youcai Zhu; Li Lin; Aparna Sharma; Jianfei Tu; Xinqing Lin; Jing Cai; Ling Xu; Jisheng Li; Xiaodong Jiao; Kainan Li; Marjorie G. Zauderer; Jia Wei; Huijing Feng; Lin Wang; Yingying Du; Wang Yao; Elizabeth Dudnik; Xuefei Shi; Xiaomin Niu; Dongmei Yuan; Yanwen Yao; Jianhui Huang; Yue Feng; Yinbin Zhang; Binbin Song; Wenfeng Li; Jianfei Fu; Marina K. Baine; Pingli Sun; Hong Wang; Mingxiang Ye; Dong Wang; Zhaofeng Wang; Jing Wu; Yunyun Yang; Yuan Fang; Zhen Wang; Bin Wan; Donglai Lv; Huafei Chen; Shengjie Yang; Jing Kang; Jiatao Zhang; Chao Zhang; Lin Shi; Yina Wang; Mohamed Emam Sobeih; Bihui Li; Bin Lian; Lili Mao; Zhang Zhang; Ke Wang; Zhongwu Li; Zhefeng Liu; Nong Yang; Lin Wu; Xiaobing Chen; Gu Jin; Miao Li; Guansong Wang; Thomas U. Marron; Jiandong Wang; Sanjay Popat; Meiyu Fang; Yong Fang; Daniel Mansilla; Yuan Li; Xiaojia Wang; Jing Chen; Yiping Zhang; Xixu Zhu; Yi Shen; Shenglin Ma; Aaron S. Mansfield; Biyun Wang; Lu Si; Anja C. Roden; Bjørn H. Grønberg; Yong Song; Geoffrey I. Shapiro; Christopher A. French; Yuanzhi Lu; Qian Wang; Chunwei Xu
errShare
errSave
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
err2025-07-22
err0
PREAI
errSolange Peters; Christian Schulz; Martin Reck; Kumar Prabhash; Dariusz Kowalski; Aleksandra Szczesna; Baohui Han; Achim Rittmeyer; Toby Talbot; David Vicente; Raffaele Califano; Diego Cortinovis; Anh Tuan Le; Dingzhi Huang; Geoffrey Liu; Federico Cappuzzo; Jessica Reyes Contreras; Ramon Palmero; Milena Perez Mak; Sanjay Popat; Youyou Hu; Stefanie Morris; Minu K. Srivastava; Monika Kaul; Vilma Graupner; Barbara Gitlitz; Siow Ming Lee
errShare
errSave
Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England
err2025-07-17
err0
errOAAI
errEseosa Grace Igbinosa; Bodini Dharmasekara; Jennifer K Quint; Sanjay Popat; Krishnan Bhaskaran; Daniel Morganstein; Sarah Cook
errShare
errSave
Updated treatment recommendation for systemic treatment: from the ESMO oncogene-addicted metastatic NSCLC Living Guideline†
err2025-06-24
err0
PREAI
errL.E.L. Hendriks; F. Cortiula; D. Martins-Branco; E. Mariamidze; S. Popat; M. Reck
errShare
errSave
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC
err2025-06-23
err0
errOAAI
errSabine Schmid; Georgia Dimopoulou; Paul van Schil; David König; Laetitia Mauti; Malinda Itchins; Martin Früh; Kersti Oselin; Lorenza Landi; Maurice Pérol; Sanjay Popat; Clemens Aigner; Patrick Forde; Wouter K. de Jong; Heidi Roschitzki-Voser; Eva Grolimund; Barbara Ruepp; Benjamin Solomon; Stephen Finn; Urania Dafni; Solange Peters
errShare
errSave
Updated treatment recommendations for systemic treatment: from the ESMO non-oncogene-addicted-metastatic NSCLC Living Guideline
err2025-06-19
err0
PREAI
errL.E.L. Hendriks; F. Cortiula; D. Martins-Branco; E. Mariamidze; S. Popat; M. Reck
errShare
errSave